Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Understanding CAN/CSA C22.2 No. 60601-2-23-12: Safety and Performance Requirements for Transcutaneous Partial Pressure Monitoring Equipment
A comprehensive guide to the Canadian standard for transcutaneous PtcO₂ and PtcCO₂ monitors
Introduction
CAN/CSA C22.2 No. 60601-2-23-12 (2016) is the Canadian adoption of the international standard IEC 60601-2-23, which specifies particular requirements for the basic safety and essential performance of transcutaneous partial pressure monitoring equipment. This equipment is used for non-invasive measurement of oxygen (PtcO₂) and carbon dioxide (PtcCO₂) partial pressures through the skin, most commonly in neonatal intensive care, respiratory monitoring, and vascular assessment. Compliance with this standard is mandatory for manufacturers seeking Canadian certification under the CSA mark or provincial regulatory approvals.
This article provides a detailed overview of the standard’s scope, core technical requirements, implementation considerations, and compliance pathways, along with practical guidance for design engineers and regulatory specialists.
Scope of the Standard
CAN/CSA C22.2 No. 60601-2-23-12 applies to transcutaneous partial pressure monitoring equipment (TPPME) intended for clinical use, including:
- Stand-alone monitors and modules integrated into multiparameter patient monitors.
- Sensor assemblies, including heater and electrode components.
- Calibration units and related accessories necessary for the measurement.
The standard covers both oxygen and carbon dioxide sensing technologies (e.g., electrochemical, optical) and applies to equipment used on patients of all ages, from neonates to adults. It does not apply to transcutaneous monitors designed solely for research or veterinary use. The standard forms a horizontal complement to the general standard CAN/CSA C22.2 No. 60601-1 and the collateral standards for medical electrical systems and alarms.
Tip: When defining the intended use of your device, clearly state whether it supports PtcO₂, PtcCO₂, or both. This directly determines which clauses of the standard apply and the extent of performance testing required.
Technical Requirements and Essential Performance
The standard defines essential performance as the ability of the equipment to accurately measure and display partial pressure values within specified limits while maintaining safe sensor skin interface temperature. Key technical requirements include:
Measurement Accuracy and Drift
The standard mandates maximum permissible errors for PtcO₂ and PtcCO₂ readings under specified test conditions. Additionally, long-term drift after sensor stabilization must not exceed defined thresholds. The table below summarizes the main performance criteria.
| Parameter | PtcO₂ Requirement | PtcCO₂ Requirement |
|---|---|---|
| Measurement range | 0–200 mmHg | 0–150 mmHg |
| Accuracy (in vitro, 37°C) | ±2% of reading ± 2 mmHg | ±5% of reading ± 2 mmHg |
| Response time (t90) | ≤ 40 seconds | ≤ 80 seconds |
| Drift per hour (after warm-up) | < 0.5% / h | < 0.5% / h |
| Sensor temperature stability | ±0.2°C over 4 h | ±0.2°C over 4 h |
| Maximum skin temperature | 44.0°C for adults; 43.5°C for neonates | 44.0°C for adults; 43.5°C for neonates |
Temperature Control and Burn Prevention
The sensor must maintain a stable temperature at the skin–electrode interface, typically between 42°C and 44°C for oxygen sensing (to achieve arterialization) and around 42°C for CO₂. The standard requires a dual-fault tolerant temperature control system: if the primary control fails, a secondary independent limiter must prevent skin temperature from exceeding 45°C. Audible and visual alarms must activate on over-temperature conditions.
Warning: Never exceed the maximum allowed skin temperature values specified in Table 201.101 of the standard. Doing so can cause first- or second-degree burns even during short-term monitoring, especially in neonatal patients with fragile skin.
Alarm and Safety Functions
CAN/CSA C22.2 No. 60601-2-23-12 requires alarms for high and low PtcO₂/PtcCO₂ thresholds, sensor disconnection, and hardware faults. Alarm systems must conform to the collateral standard CSA C22.2 No. 60601-1-8, which classifies alarms by priority (high, medium, low). For example, a high-priority alarm must be generated when measured values exceed adjustable clinical limits by 20% or more.
Implementation Highlights for Manufacturers
To achieve compliance during product development, manufacturers should focus on the following areas:
- Sensor Design: Choose electrode materials and membranes that meet the accuracy and drift requirements. Conduct extensive stability testing over the declared operational life.
- Calibration Procedures: The standard defines two-point calibration (zero and span) using certified gas mixtures. Automated self-calibration cycles must be validated to ensure repeatability.
- Usability Engineering: Apply IEC 60601-1-6 and CAN/CSA C22.2 No. 60601-1-11 (for home healthcare if applicable) to minimize user-interface errors. The monitor should clearly display sensor status, trending, and alerts.
- Electromagnetic Compatibility (EMC): As per the fourth edition of IEC 60601-1-2, transcutaneous monitors must not be susceptible to typical hospital RF fields, especially from electrosurgical units and MRI equipment (when used nearby).
Success Path: Many manufacturers now implement temperature control with triple redundancy (PID control, hardware limiter, and a secondary safety microcontroller). This robust approach satisfies the essential performance objectives and simplifies certification review.
Compliance and Certification Considerations
To obtain CSA certification for transcutaneous monitoring equipment, manufacturers must demonstrate conformity to the standard through a combination of analysis, testing, and quality management. Key steps include:
- Reviewing the Canadian national deviations published in Official Bulletin 24 (OB 24) or the CSA C22.2 series updates.
- Submitting a compliance report from an accredited testing body (e.g., CSA Group, Intertek, or TÜV SÜD) that covers the IEC 60601-1 general standard, IEC 60601-2-23 particular requirements, and any applicable collateral standards.
- Providing documentation for software validation, risk management (ISO 14971), and clinical evaluation (for novel measurement technologies).
- Ensuring that the device marking includes the supplier identification, model, date of manufacture, and the safety symbols required by the standard.
Compliance Risk: Incomplete testing of the temperature limiting system is one of the most frequent non-conformities found during audits. Manufacturers often forget to test the secondary shutdown with a simulated single-fault condition (e.g., cutting the main heater feedback loop). Always include this in your design verification plan.
Frequently Asked Questions
Q: What types of equipment does CAN/CSA C22.2 No. 60601-2-23-12 cover?
A: It covers transcutaneous partial pressure monitors for PtcO₂ and PtcCO₂, including all components from sensor to display, calibration devices, and accessories intended for clinical use on humans. Equipment solely for veterinary or research applications is excluded.
A: It covers transcutaneous partial pressure monitors for PtcO₂ and PtcCO₂, including all components from sensor to display, calibration devices, and accessories intended for clinical use on humans. Equipment solely for veterinary or research applications is excluded.
Q: How does this Canadian standard differ from the international IEC 60601-2-23?
A: The Canadian version is technically identical to the IEC standard but includes national deviations required by the Canadian Electrical Code and Canadian regulatory framework. These deviations mainly affect compliance markings, language requirements on labeling (English and French), and certain test voltage levels. The document number incorporates the 2012 edition year, with consistency updates up to the 2016 publication.
A: The Canadian version is technically identical to the IEC standard but includes national deviations required by the Canadian Electrical Code and Canadian regulatory framework. These deviations mainly affect compliance markings, language requirements on labeling (English and French), and certain test voltage levels. The document number incorporates the 2012 edition year, with consistency updates up to the 2016 publication.
Q: What are the most critical essential performance criteria for transcutaneous monitors?
A: The most critical criteria are accurate partial pressure measurement (within ±2% for O₂, ±5% for CO₂), precise sensor temperature control (including failsafe limits), appropriate alarm generation for physiological and technical alarms, and minimal drift to assure long-term reliability during extended monitoring sessions.
A: The most critical criteria are accurate partial pressure measurement (within ±2% for O₂, ±5% for CO₂), precise sensor temperature control (including failsafe limits), appropriate alarm generation for physiological and technical alarms, and minimal drift to assure long-term reliability during extended monitoring sessions.
Q: Is in-house calibration sufficient for compliance?
A: Yes, the standard allows calibration to be performed by the system before each use or at regular intervals specified by the manufacturer. However, the calibration process must be validated, and compliance requires that calibration gases have documented traceability to international standards such as NIST or NRC Canada.
A: Yes, the standard allows calibration to be performed by the system before each use or at regular intervals specified by the manufacturer. However, the calibration process must be validated, and compliance requires that calibration gases have documented traceability to international standards such as NIST or NRC Canada.
— This article is intended for informational purposes. Always refer to the latest version of CAN/CSA C22.2 No. 60601-2-23-12 and consult a qualified certification body for compliance requirements.
Article revision: 2026